This course is part of the MCO Leadership New Session Review curriculum.
Doctor placing sensors on a patient

This course is part of the MCO Leadership New Session Review curriculum.

Webcast

Acute Coronary Syndrome: Evaluation, Diagnosis, and Management

This talk will cover the evaluation of chest pain and diagnosis of acute coronary syndrome, with a focus on the criteria defined in the Universal Definition of Myocardial Infarction statement. There will be particular emphasis on the use of high-sensitivity troponin assays as recommended by contemporary guideline statements. Finally, we will review recommended approaches to invasive management of ACS (revascularization) and highlight contemporary medical therapies.

Begin

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 5/7/2025

Expiration Date: 6/15/2026

Learning Objectives

  • Identify the chest pain descriptors and electrocardiographic findings that support the diagnosis of ACS
  • Recognize the kinetics of cardiac troponin elevations in ACS and advantages of high-sensitivity troponin assays
  • Discuss the indications and optimal timing of coronary revascularization across the spectrum of ACS
  • Describe the core medical therapies used to reduce cardiovascular risk after ACS
     

     

Faculty

David D. Berg, MD, MPH

Investigator | TIMI Study Group
Cardiovascular Division
Brigham and Women's Hospital
Assistant Professor of Medicine Harvard Medical School
Boston, MA

Learn More

Disclosures

The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All have been mitigated by Pri-Med Institute:

David D. Berg, MD, MPH:
Researcher for AstraZeneca, Pfizer; Consultant for AstraZeneca, Mobility Bio, Pfizer, Youngene Therapeutics; Speaker for USV Private Limited; Other for Beckman Coulter, Kowa Pharmaceuticals, and Tosoh Biosciences.

All others in control of content for this activity have disclosed no relevant financial relationships.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.

Acute Coronary Syndrome: Evaluation, Diagnosis, and Management

Begin